RILEXINE ONCE A DAY CEPHALEXIN ORAL ANTIBIOTIC PASTE FOR CATS AND DOGS

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Buy It Now

Active ingredient:

CEPHALEXIN AS CEPHALEXIN MONOHYDRATE

Available from:

VIRBAC (AUSTRALIA) PTY LTD

Class:

Veterinary Medicine

Therapeutic group:

CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY

Therapeutic area:

ANTIBIOTIC & RELATED

Therapeutic indications:

INFECTIONS OF THE URINARY TRACTS | PYODERMA | ESCHERICHIA COLI | GROUP D STREPTOCOCCUS | KLEBSIELLA SPP. | PROTEUS SPP. | PSEUDOMONAS AERUGINOSA | STAPHYLOCOCCUS SPP.

Authorization status:

Registered

Authorization date:

2002-01-29

Patient Information leaflet

                                CONDITIONS OF ARTWORK *
IT IS THE PURCHASERS RESPONSIBILITY TO CHECK 
THIS ARTWORK CAREFULLY TO ENSURE ALL DETAILS  
ARE CORRECT AS NO LIABILITY WILL BE ACCEPTED  
AFTER PRINTING.
PLEASE FAX BACK SIGNED PROOF TO:
(02) 9502 3444
❏
 
THE SAMPLE IS CORRECT AND SATISFACTORY.
 
❏
 
REVISED PROOF REQUIRED.
Signature.......................................................
Date:....................................
CLIENT:
Virbac
ATTN:
Amelia Abouzeid
_Passionate about animal health_
ACTIVE CONSTITUENT:  200mg/mL CEPHALEXIN (as MONOHYDRATE)
FOR THE TREATMENT OF ACUTE URINARY TRACT INFECTIONS IN CATS AND DOGS,
AND
PYODERMA IN DOGS, CAUSED BY BACTERIA SUSCEPTIBLE TO CEPHALEXIN
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
5.25ML SYRINGE
ACTIONS
PHARMACOLOGY
Cephalexin is a first-generation cephalosporin antibiotic, with a
bactericidal mode of action:
cephalexin interferes with bacterial cell-wall synthesis resulting in
bacterial lysis. Cephalexin
is considered a broad spectrum antibiotic, since it displays efficacy
against both gram-
positive and gram-negative bacteria. However, in common with the
first-generation 
cephalosporins generally, cephalexin provides excellent coverage
against most gram-positive 
organisms, but variable coverage against gram-negative organisms.
Cephalexin is resistant 
to staphylococcal penicillinase, but is sensitive to B-lactamases
produced by many gram-
negative organisms.
These details are reflected in cephalexin MIC (Minimal Inhibitory
Concentration) data from 
in-vitro cephalexin MIC studies involving bacteria isolated from
clinical cases of canine pyo-
derma / dermatitis and acute cases of canine and feline urinary tract
infections.
Results from the MIC studies indicate that the majority of bacterial
strains associated with 
acute canine and feline lower urinary tract infections and canine
pyoderma / dermatitis are
susceptible to cephalexin. As expected from a first generation
cephalosporin, cephalexin 
shows very good eff
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                VIRBAC (AUSTRALIA) PTY. LTD. 
DOCUMENT NO: 
RILEXINE PASTE 
REVISION C 
MATERIAL SAFETY DATA SHEET 
Product Name: 
Rilexine Once a Day Cephalexin Oral Antibiotic Paste for Cats and 
Dogs 
PAGE: 1 OF 5
DATE OF ISSUE
17 SEPTEMBER, 
2008
 
EMERGENCY: VIRBAC: 02 9772 9772 OR 1800 242 100 (BUSINESS HOURS
ONLY) 
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND) 
SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY  
COMPANY: 
VIRBAC (AUSTRALIA) PTY. LTD 
ABN 77 003 268 871
 
ADDRESS 
361 Horsley Rd, Milperra, NSW 2214, Australia 
 
Locked Bag 6000, Milperra Business Centre, NSW 1891, Australia 
TELEPHONE: 
(02) 9772 9772 or 1800 242 100 
FAX: 
(02) 9772 9773 
EMERGENCY PHONE 
As above during business hours; answering machine after hours 
SUBSTANCE:  
Active ingredient is a cephalosporin type antibiotic.
 
TRADE NAME:  
Rilexine Once a Day Cephalexin Oral Antibiotic Paste for Cats and
Dogs
 
PRODUCT USE:  
Treatment of urinary tract infections in cats and dogs, and pyoderma
in dogs, caused 
by bacteria susceptible to Cephalexin.
 
CREATION DATE: 
JUNE, 2002 
REVISION DATE: 
JANUARY, 2008 
SECTION 2 - HAZARDS IDENTIFICATION 
STATEMENT OF HAZARDOUS NATURE  
This product is classified as: Not classified as hazardous
according to the criteria of ASCC Australia.  
Not a Dangerous Good according to the Australian Dangerous Goods
(ADG) Code.
 
RISK PHRASES: Not Hazardous - No criteria found. 
SAFETY PHRASES: Not Hazardous - No criteria found. 
SUSDP CLASSIFICATION: S4 
ADG CLASSIFICATION: None allocated. Not a Dangerous Good. 
UN NUMBER: None allocated 
EMERGENCY OVERVIEW 
PHYSICAL DESCRIPTION & COLOUR: Creamy yellow coloured paste.
Presented in 5.25 and 10.5mL syringes. 
ODOUR: Odour of anchovy. 
MAJOR HEALTH HAZARDS: No major health hazards are known. However,
persons allergic to penicillins should avoid 
using this product. 
POTENTIAL HEALTH EFFECTS 
Cephalexin has occasionally b
                                
                                Read the complete document
                                
                            

Search alerts related to this product